Eva Ruiz-Hispán

6PUBLICATIONS
25CO-AUTHORS
Forest health and pathologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2026
Correction: Guadalajara et al. Impact on Clinical- and Patient-Reported Outcomes Measures of an Organ Preservation-Based Therapeutic Strategy in Locally Advanced Rectal Cancer: The FOREST Project. J. Clin. Med. 2026, 15, 844.

|Jul 29, 2026
SEPTIN9 Gene Methylation Ratio as Follow-Up Biomarker in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

|Jan 28, 2026
Impact on Clinical- and Patient-Reported Outcomes Measures of an Organ Preservation-Based Therapeutic Strategy in Locally Advanced Rectal Cancer: The FOREST Project.

Hector Guadalajara, Ion Cristóbal, Raquel Fuentes-Mateos

|Dec 30, 2025
Radiopathological Correlation in Locally Advanced Rectal Cancer After Neoadjuvant Treatment.

Mario Martín-Sánchez, Pedro Villarejo Campos, Víctor Domínguez-Prieto

|Jul 25, 2025
Derivation and External Validation of Objective Performance Status Among Patients With Metastatic Cancer.

Eva Ruiz, Christopher R Manz, Anthony Girard

|Mar 28, 2025
Pre-Treatment SEPTIN9 Gene Methylation Ratio Predicts Tumor Response to Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.

Víctor Domínguez-Prieto, Miguel León-Arellano, Rocío Olivera-Salazar

Pageof 1

Frequent Collaborators

5 joint publications

Damián García-Olmo

4 joint publications

Héctor Guadalajara

3 joint publications

Víctor Domínguez-Prieto

2 joint publications

Ion Cristóbal